Serono

News Serono

• Q2/2010: Merck Profit After Tax Jumps 70% to EUR 187 Million

  All four divisions of the Merck Group, especially the Chemicals divisions, recorded increases in second-quarter 2010 revenues, leading to a record EUR 2,208 million in total revenues for the Group. This was a 16% increase compared to the year-ago amount of EUR 1,910 million. In the first half of 201 more

• Clavis Pharma announces the appointment of Athos Gianella-Borradori, MD

  Clavis Pharma ASA announces the appointment of Athos Gianella-Borradori MD as Chief Medical Officer (CMO). Dr Gianella-Borradori is an experienced onco-hematologist and drug developer, with 30 years experience in the field. He spent the past 20 years in industry, focused on translational research a more

• New members for Neurotune's Board of Directors

  The shareholders of Neurotune AG have elected Dr. Anders Härfstrand and Heinrich Rotach as new members of the board of directors at their annual general assembly on April 21, 2010. Anders Härfstrand is a medical doctor with extensive experience in neuropharmacology and an excellent track record as e more

Market studies Serono

• Tecan Group Ltd (TECN) - Financial and Strategic SWOT Analysis Review

  Tecan Group (Tecan) is engaged in the development, manufacturing and distribution of automation solutions for life science laboratories. It is the major supplier of laboratory instruments and solutions for the biopharma, forensic and diagnostic industries. In addition, it also deals with the automat more

Websites Serono